通过专为投资者打造的一站式数据看板，全面查看 Viridian Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

2.37B

股息TTM

0.00

市盈率 TTM

-5.36

每股收益TTM

-4.00

营业收入

70.85M

净利润

-269.95M

净资产收益率

-78.43%

总资产收益率

-49.74%

Viridian Therapeutics Inc 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

财务指标

每股收益

4.56%-1.18

3.94%-1.03

-28.05%-1.27

63.36%-0.42

-21.30%-1.23

-34.48%-1.07

25.83%-0.99

-5.76%-1.15

20.05%-1.02

50.76%-0.79

-19.04%-1.34

---1.09

---1.27

---1.61

---1.13

---2.88

----

营业收入

278.67%284.00K

95.83%141.00K

83.33%132.00K

81958.14%70.57M

4.17%75.00K

0.00%72.00K

19.44%86.00K

0.00%72.00K

-26.53%72.00K

-31.43%72.00K

-93.97%72.00K

-71.88%72.00K

-54.63%98.00K

-50.93%105.00K

474.52%1.20M

-76.51%256.00K

-85.11%216.00K

296.30%214.00K

--208.00K

净利润

-26.19%-127.12M

-20.70%-104.90M

-50.96%-120.36M

54.88%-34.60M

-54.99%-100.73M

-79.04%-86.91M

-19.24%-79.72M

-60.91%-76.69M

-18.03%-64.99M

28.77%-48.54M

-46.03%-66.86M

-64.88%-47.66M

-86.71%-55.06M

-165.25%-68.15M

-58.17%-45.78M

-105.83%-28.91M

-64.17%-29.49M

-39.18%-25.69M

68.10%-28.95M

-155.61%-14.04M

利润率

66.67%-44760.21%

38.37%-74397.87%

17.66%-91178.03%

99.95%-49.03%

-48.79%-134313.33%

-79.04%-120711.11%

-19.24%-110729.17%

-34.71%-89173.26%

-18.03%-90268.06%

3.05%-67419.44%

-112.96%-92861.11%

---66194.44%

---76476.39%

---69541.84%

---43604.76%

---5044.33%

----

毛利率

0.00%100.00%

--100.00%

----

资产负债率

808.37%32.43%

250.43%10.97%

237.61%9.36%

36.14%3.62%

2.23%3.57%

-2.95%3.13%

-32.71%2.77%

-56.30%2.66%

160.63%3.49%

166.58%3.22%

285.91%4.12%

--6.08%

--1.34%

--1.21%

--1.07%

--1.05%

----

利润表

营业收入

278.67%284.00K

95.83%141.00K

83.33%132.00K

81958.14%70.57M

4.17%75.00K

0.00%72.00K

19.44%86.00K

0.00%72.00K

-26.53%72.00K

-31.43%72.00K

-93.97%72.00K

-71.88%72.00K

-54.63%98.00K

-50.93%105.00K

474.52%1.20M

-76.51%256.00K

-85.11%216.00K

296.30%214.00K

--208.00K

营业利润

-18.27%-126.27M

-23.76%-116.17M

-40.33%-122.75M

52.07%-40.01M

-47.90%-106.77M

-67.93%-93.87M

-22.38%-87.47M

-62.97%-83.48M

-21.78%-72.19M

22.87%-55.90M

-45.68%-71.48M

-71.98%-51.22M

-100.50%-59.27M

-179.94%-72.47M

-68.72%-49.07M

-110.73%-29.79M

-64.26%-29.56M

-39.83%-25.89M

-40.41%-29.08M

-165.33%-14.13M

净利润

-26.19%-127.12M

-20.70%-104.90M

-50.96%-120.36M

54.88%-34.60M

-54.99%-100.73M

-79.04%-86.91M

-19.24%-79.72M

-60.91%-76.69M

-18.03%-64.99M

28.77%-48.54M

-46.03%-66.86M

-64.88%-47.66M

-86.71%-55.06M

-165.25%-68.15M

-58.17%-45.78M

-105.83%-28.91M

-64.17%-29.49M

-39.18%-25.69M

68.10%-28.95M

-155.61%-14.04M

资产负债表

流动资产

86.83%1.08B

19.40%784.74M

21.09%894.23M

-25.47%571.91M

-0.50%578.75M

4.85%657.24M

51.80%738.46M

136.96%767.36M

67.95%581.66M

63.83%626.82M

12.83%486.48M

-25.96%323.84M

108.44%346.33M

113.28%382.60M

115.41%431.17M

100.68%437.36M

43.90%166.15M

47.60%179.39M

54.43%200.16M

581.66%217.94M

流动负债总额

21.32%63.79M

53.60%51.80M

47.67%70.70M

22.56%50.70M

43.04%52.59M

29.09%33.73M

79.74%47.87M

77.93%41.36M

28.28%36.76M

-11.70%26.13M

-20.13%26.64M

-7.80%23.25M

33.99%28.66M

105.67%29.59M

144.57%33.35M

75.84%25.21M

27.08%21.39M

-12.47%14.39M

27.75%13.64M

89.72%14.34M

总资产

88.42%1.10B

19.37%789.02M

21.15%899.42M

-25.23%577.14M

-0.57%582.32M

4.85%660.98M

51.38%742.40M

134.79%771.90M

66.63%585.66M

63.04%630.38M

12.72%490.42M

-25.38%328.76M

106.97%351.47M

111.09%386.64M

113.58%435.09M

99.17%440.58M

43.66%169.81M

49.12%183.16M

55.20%203.71M

573.73%221.21M

总负债

547.96%435.14M

170.77%153.01M

150.48%177.25M

15.16%74.17M

19.23%67.16M

18.09%56.51M

46.20%70.76M

42.55%64.40M

58.17%56.33M

32.58%47.85M

20.92%48.40M

43.10%45.18M

27.56%35.61M

118.44%36.09M

150.28%40.03M

90.04%31.57M

44.72%27.92M

-1.85%16.52M

42.57%15.99M

40.90%16.61M

总权益

28.52%662.10M

5.22%636.01M

7.52%722.17M

-28.91%502.97M

-2.68%515.17M

3.77%604.47M

51.95%671.64M

149.49%707.50M

67.59%529.34M

66.18%582.53M

11.89%442.02M

-30.67%283.58M

122.59%315.86M

110.36%350.55M

110.46%395.06M

99.91%409.01M

43.46%141.90M

57.21%166.64M

56.38%187.72M

872.30%204.59M

现金流量表

经营净额

-39.74%-105.32M

-29.14%-119.65M

67.61%-23.75M

-24.97%-84.61M

-63.65%-75.37M

-104.88%-92.65M

-92.98%-73.33M

-73.68%-67.71M

-1.87%-46.06M

27.03%-45.22M

-11.63%-38.00M

-88.62%-38.98M

-149.99%-45.21M

-194.52%-61.97M

-105.87%-34.04M

-74.05%-20.67M

-23.61%-18.09M

-82.36%-21.04M

-75.24%-16.54M

-133.07%-11.88M

投资净额

-405.29%-231.16M

-22.79%77.26M

-439.49%-339.42M

248.91%126.08M

22.17%75.72M

169.95%100.06M

62.93%-62.91M

-276.24%-84.67M

52.23%61.98M

-975.93%-143.04M

6.03%-169.71M

12.64%48.04M

191.58%40.71M

-250.01%-13.29M

-125.16%-180.60M

582.31%42.65M

224.61%13.96M

-18.48%8.86M

-52.99%-80.21M

11894.34%6.25M

融资净额

42455.10%325.12M

-30.99%6.36M

1042.63%405.91M

-95.57%10.86M

607.41%764.00K

-94.80%9.21M

-82.14%35.52M

1485.19%245.02M

-96.48%108.00K

2058.48%177.08M

664.75%198.94M

-94.69%15.46M

-32.69%3.07M

1011.65%8.20M

15202.35%26.01M

149.10%290.93M

-35.37%4.56M

-41.38%738.00K

-99.78%170.00K

2414.40%116.79M

营业收入

业务

报告期:

暂无数据

地区

报告期:

暂无数据

常见问题

Viridian Therapeutics Inc的总收入是多少？



根据Viridian Therapeutics Inc的FY2025财报，总收入达到了70.85M（同比变化302.00K）。

Viridian Therapeutics Inc的流动资产是多少？



根据Viridian Therapeutics Inc的FY2025财报，流动资产为894.23M（同比变化21.09）。

Viridian Therapeutics Inc的总资产是多少？



根据Viridian Therapeutics Inc的FY2025财报，Viridian Therapeutics Inc的总资产为899.42M（同比变化21.15）。

Viridian Therapeutics Inc的总负债是多少？



根据Viridian Therapeutics Inc的FY2025财报，Viridian Therapeutics Inc的总负债为177.25M（同比变化150.48）。

Viridian Therapeutics Inc的总权益是多少？



根据Viridian Therapeutics Inc的FY2025财报，Viridian Therapeutics Inc的总权益为722.17M（同比变化7.52）。

Viridian Therapeutics Inc的净营业收入是多少？



根据Viridian Therapeutics Inc的FY2025财报，Viridian Therapeutics Inc的净营业收入为-324.92M（同比变化-8.66）。

Viridian Therapeutics Inc的净投资是多少？



根据Viridian Therapeutics Inc的FY2025财报，Viridian Therapeutics Inc的净投资为-37.56M（同比变化83.57）。

Viridian Therapeutics Inc的净融资是多少？



根据Viridian Therapeutics Inc的FY2025财报，Viridian Therapeutics Inc的净融资为426.74M（同比变化-6.77）。

Viridian Therapeutics Inc的每股收益（EPS）是多少？



根据Viridian Therapeutics Inc的FY2025财报，每股收益（EPS）为-4.04（同比变化-1.60）。

Viridian Therapeutics Inc的净利润是多少？



根据Viridian Therapeutics Inc的FY2025财报，净利润为-342.60M（同比变化-26.91）。

Viridian Therapeutics Inc的净利润率是多少？



根据Viridian Therapeutics Inc的FY2025财报，净利润率为-483.57（同比变化99.46）。

Viridian Therapeutics Inc的债务与资产比率是多少？



根据Viridian Therapeutics Inc的FY2025财报，债务与资产比率为9.36（同比变化237.61）。

Viridian Therapeutics Inc的股东权益回报率（ROE）是多少？



根据Viridian Therapeutics Inc的FY2025财报，股东权益回报率（ROE）为-63.87（同比变化15.03）。

Viridian Therapeutics Inc的资产回报率（ROA）是多少？



根据Viridian Therapeutics Inc的FY2025财报，资产回报率（ROA）为-41.73（同比变化4.70）。

Viridian Therapeutics Inc的营业利润是多少？



根据Viridian Therapeutics Inc的FY2025财报，营业利润为-324.92M（同比变化-8.66）。